IOCN 'Ask a Question' Webinar Series


This is a monthly free interactive webinar with cases and questions answered by a panel of experts. Join us to find out the answers to the questions you have on a different topic each month!


The'Ask a Question' webinar series is kindly sponsored by Merck Serono

Ask a Question: A Focus on Colitis

Tuesday 1st October 2024

18:30 - 20:00


Sign up Here

Ask a Question:

A Focus on Ophthalmic Toxicities

Tuesday 29th October 2024

18:30 - 20:00


Sign up Here

Ask a Question - A Focus on Rheumatological Toxicities

(Non Athralgia, Vasculitis and GCA)


Tuesday 19th November 2024

18:30 - 20:00


Sign up Here

IOCN 'New & Novel' Webinar Series


The field of immunotherapy for solid cancers is rapidly expanding beyond immune checkpoint inhibitors, bringing new challenges and toxicities for healthcare professionals to navigate. To address these issues, the IOCN is hosting a 'New and Novel' webinar series, generously sponsored by Amgen. This series will consist of four webinars focused on cutting-edge immunotherapeutics and their associated side effects, including CRS, HLH, and ICANS. Each webinar will be led by experts in the field, with ample opportunity for attendees to ask questions.


Join us for this informative series to deepen your understanding of novel immunotherapeutics and their side effects

Introduction to Novel Immunotherapeutics

Monday 7th October 2024

18:30 - 19:30


Sign up here

Cytokine Release Syndrome (CRS)

Monday 25th November 2024

18:30 - 19:30


Sign up here

Immune effector cell-associated neurotoxicity syndrome (ICANS)

Monday 28th October 2024

18:30 - 19:30


Sign up here

Hemophagocytic Lymphohistiocystosis (HLH)

Monday 27th January 2025

18:30 - 19:30


Sign up here

Other Immuno-Oncology Educational Events and Courses


  • Oncology National Networking Forums - Achieving Successful Assessments of Patients on Immuno-Oncology - Thursday 12th September 2024 (Online Course)

    Designed for healthcare professionals leading assessments of patients on immunotherapy. Led by Dr Anna Olsson Brown, this online course will equip you with practical, implementable tools, crucial guidance and new skills to ensure safe, competent and effective assessment of patient with IO Toxicity flare-ups.

    View full forum details >>


  • Oncology National Networking Forums - Practical Management of Immuno-Oncology: Service Development - Thursday 24th October 2024, Village Hotel, Coventry.

    Achieving consistency in IO Services across the country: streamlined guidance and support.

    With a key focus on service development, this in-person conference has been designed for all healthcare proffesionals working in Immuno-oncology or Acute Oncology who ar elooking to action and plan for the future of their service.

    View full forum details >>


  • Clatterbridge Cancer Centre Immuno-Oncology Study Day - Monday 04th of November 2024
    Join the CCC team of expert IO professionals as they explore the key considerations when managing patients with immune related Adverse Events (irAEs), identifying how you can improve your own knowledge and practice when supporting patients who are undergoing immunotherapy.

         Find out more information and book here.


  • University of Birmingham -Understanding immune checkpoint blockade therapy: a pillar of modern cancer treatment

    An online 8 week course designed to benefit healthcare professionals, individuals working in industry, oncologists and cancer specialists, non-cancer specialists such as geneticists and basic immunologists, as well as patient groups and students (MSc, medical and undergraduates) with a background in science.

    Find out more information on the University of Birmingham website here.

IOCN Service Showcase

Coming Soon!


The IOCN will be launching the Service Showcase webinar series in 2025!


Each webinar we will invite healthcare professionals from different trusts to discuss how they have developed an immunotherapy toxicity service, including the logistics, practicalities and governance of setting up a service. We are aware that immunotherapy toxicity services vary greatly throughout the UK and no one size fits all. The aim of this showcase is therefore to highlight how different services have been set up and run.